Jim Simons Gbs Inc. Transaction History

Renaissance Technologies LLC

  • $56.7 Billion
  • Q2 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 13, 2023
SELL
$0.0 - $0.47 $0 - $1,034
-2,200 Reduced 2.06%
104,800 $21,000
Q3 2022

Nov 14, 2022
SELL
$0.39 - $0.79 $1,911 - $3,871
-4,900 Reduced 4.38%
107,000 $45,000
Q2 2022

Aug 12, 2022
BUY
$0.56 - $1.31 $24,864 - $58,164
44,400 Added 65.78%
111,900 $74,000
Q1 2022

May 13, 2022
BUY
$0.43 - $1.7 $29,025 - $114,750
67,500 New
67,500 $53,000

Others Institutions Holding GBS

# of Institutions
1
Shares Held
0
Call Options Held
0
Put Options Held
0
View Full List

About GBS Inc.

GBS Quotes by TradingView
  • Ticker GBS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 14,889,900
  • Description
  • GBS Inc. operates as a biosensor diagnostic technology company. It offers Saliva Glucose Biosensor that uses saliva to measure glucose non-invasively. The company also focuses on developing COV2 test, a biosensor test can be used as a complement to the (RNA) virus detection test; and a biosensor platform comprising of biochemistry, immunology, t...
More about GBS
Track Jim Simons's Portfolio

Track Jim Simons Portfolio

Follow Jim Simons (Renaissance Technologies LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Renaissance Technologies LLC, based on Form 13F filings with the SEC.

News

Stay updated on Renaissance Technologies LLC and Jim Simons with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email